Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company XL-protein GmbH
DescriptionLong-acting formulation of human growth hormone (hGH) using PASylation technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationGrowth hormone deficiency
Indication DetailsGrowth hormone deficiency
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today